drugset / Trial / NCT05291455

Lacosamide in Neonatal Status Epilepticus

NCT05291455

Phase 3 Unknown 60 enrolled Tanta University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Lacosamide in neonatal status epilepticus

Timeline

Start
2022-03-01
Primary completion
2024-03-01
Completion
2024-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lacosamide Other / unclassified
Comparator Phenobarbital Unknown

Indications